FundingWatcher
Home / Investors / Biotech investors / Biotech investors in New York, United States

Biotech investors in New York, United States

Updated 16 Nov 2026

Reset

Venture funds

10 funds, by portfolio companies funded in the last 12 months
#FundSectorsStages LeadsFunded, 12 months
1 Bristol-Myers Squibb
Bristol-Myers Squibb develops and sells pharmaceuticals, with recent investments including BigHat Biosciences and Ratio Therapeutics.
New York, United States
Biotech, Health care Early stage venture 30% 4
2 Pfizer
Pfizer is a biopharmaceutical company developing medicines and vaccines, with recent companies including Circle Pharma, CellCentric and FoRx Therapeutics.
New York, United States
Biotech, Health care 40% 3
3 2048 Ventures
2048 Ventures is a thesis-driven venture firm, recently backing TwoStep Therapeutics and Genius AI.
New York, United States
Artificial intelligence, Fintech Seed, Early stage venture 67% 2
4 BoxGroup
BoxGroup invests in early-stage technology companies, with recent investments including Nominal and Northwood Space.
New York, United States
Artificial intelligence, Fintech Seed, Early stage venture 5% 2
5 Casdin Capital
Casdin Capital does fundamental research investing in life sciences and healthcare, with recent companies Multiply Labs and Thyme Care.
New York, United States
Health care, Biotech Seed, Early stage venture, Late stage venture 15% 2
6 Digitalis Ventures
Digitalis Ventures invests in solutions to complex problems in human and animal health, including T-Therapeutics and Reema Health.
New York, United States
Health care, Biotech Seed, Early stage venture, Late stage venture 16% 2
7 Everywhere Ventures
Everywhere Ventures invests in early-stage technology companies, with recent investments including VAMA and North.cloud.
New York, United States
Artificial intelligence, Fintech Early stage venture 2% 2
8 Insight Partners
Insight Partners invests in high-growth software and Internet startups, with recent investments including Coast and Reco.
New York, United States
Artificial intelligence, Fintech Seed, Early stage venture, Late stage venture 62% 2
9 LifeX Ventures
LifeX Ventures backs technologies that extend the longevity of people and planet, with recent companies including Dash Bio and Century Health.
New York, United States
Artificial intelligence, Health care 11% 2
10 Pareto Holdings
Pareto Holdings provides venture studio and early-stage funding services, with recent investments including Mural and Ryft.
New York, United States
Fintech, Artificial intelligence Seed, Early stage venture 2% 2

Table 1. Biotech investors in New York, United States: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.

Biotech investors in New York, United States
One-time CSV
  • 72 firms, 70 with a website
  • 52 firm email addresses
  • 47 phone numbers
  • CRM-ready CSV, 15 columns
  • Download right after payment
With partner contacts
Compiled to order
  • The full list, plus the people who invest
  • Up to 2 partners per firm, compiled to order
  • Name, job title and LinkedIn where found
  • Verified direct email per person
  • List CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

investors-sector-biotech-new-york-united-states.csv72 rows × 15 columns
InvestorTypeLocationEmailPhone
TechstarsStartup acceleratorNew York, United States•••@techstars.com+1 303•••
Insight PartnersPrivate equity firmNew York, United States•••@insightpartners.com212-23•••
Big Idea VenturesStartup acceleratorNew York, United States•••@bigideaventures.com(415) •••
InvusPrivate equity firmNew York, United States•••@invus.com+1 (21•••
Casdin CapitalVenture capital firmNew York, United States•••@casdincapital.com+1 212•••
Catalio Capital ManagementVenture capital firmNew York, United States•••@cataliocapital.com(410) •••
BoxGroupVenture capital firmNew York, United States•••@boxgroup.com646-65•••
Lux CapitalVenture capital firmNew York, United States•••@luxcapital.com646.47•••

8 rows of the CSV in 5 of its 15 columns, email and phone masked.

investors-sector-biotech-new-york-united-states-contacts.csvUp to 2 verified partners per firm × 7 columns
FirmPersonTitleVerified emailLinkedIn
OrbiMedW••• P•••Managing Directorp•••@orbimed.comIn the CSV
TechstarsA••• B•••Managing Director NYC Programsa•••@techstars.comIn the CSV
Insight PartnersW••• W••• B•••Managing Directorw•••@insightpartners.comIn the CSV
InvusK••• B•••Managing Directork•••@invus.comIn the CSV
Casdin CapitalB••• C•••Senior Managing Directorb•••@casdincapital.comIn the CSV

5 verified partner contact rows from organizations on this list, names and emails masked.

72
Investors
52
With email
47
With phone
50
Active in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Biotech investors in New York, United States

30 of 72, most investments first
30 rows
# Investor Type Location Invests in Latest portfolio companies Funded, 12 months Investments Lead Exits Email Phone LinkedIn
1 OrbiMed Private equity firm New York, United States Health care, Biotech Triveni Bio, Windward Bio, Terremoto Biosciences 8 810 276 304 +1 (21••• In the CSV
2 Techstars Startup accelerator New York, United States Artificial intelligence, Fintech Zipline International, Intuitivo, MuukTest 67 6,842 3,391 638 •••@techstars.com +1 303••• In the CSV
3 Bristol-Myers Squibb Venture capital firm New York, United States Biotech, Health care BigHat Biosciences, Ratio Therapeutics, Cour Pharmaceuticals Development 4 109 33 22 (212)5••• In the CSV
4 Insight Partners Private equity firm, Venture capital firm New York, United States Artificial intelligence, Fintech Coast, Reco, Island 17 1,349 833 335 •••@insightpartners.com 212-23••• In the CSV
5 Big Idea Ventures Startup accelerator, Micro VC fund New York, United States Biotech, Health care Standing Ovation, Seprify, Innocent Meat 3 194 110 9 •••@bigideaventures.com (415) ••• In the CSV
6 Invus Private equity firm New York, United States Health care, Biotech Lycia Therapeutics, Triveni Bio 2 300 52 99 •••@invus.com +1 (21••• In the CSV
7 Casdin Capital Venture capital firm New York, United States Health care, Biotech Multiply Labs, Thyme Care, Cerevance 5 248 36 93 •••@casdincapital.com +1 212••• In the CSV
8 Catalio Capital Management Venture capital firm New York, United States Biotech, Health care Volastra Therapeutics, PinkDx, Clasp Therapeutics 134 32 30 •••@cataliocapital.com (410) ••• In the CSV
9 Perceptive Advisors Hedge fund New York, United States Health care, Biotech Bridge to Life, CereVasc, Talkiatry 3 352 116 196 (646) ••• In the CSV
10 BoxGroup Venture capital firm New York, United States Artificial intelligence, Fintech Nominal, Northwood Space, Reflex 22 866 39 161 •••@boxgroup.com 646-65••• In the CSV
11 Lux Capital Venture capital firm New York, United States Artificial intelligence, Hardware Nominal, Formic, Meow 12 672 179 76 •••@luxcapital.com 646.47••• In the CSV
12 StartUp Health Venture capital firm New York, United States Health care, Artificial intelligence 9amHealth, eddii, AvoMD 5 391 9 38 •••@startuphealth.com In the CSV
13 Blue Owl Private equity firm New York, United States Health care, Biotech Lycia Therapeutics, Windward Bio, Vestwell 4 84 38 33 •••@blueowl.com In the CSV
14 Pareto Holdings Venture capital firm New York, United States Fintech, Artificial intelligence Mural, Jar, Ryft 22 570 10 62 In the CSV
15 2048 Ventures Venture capital firm New York, United States Artificial intelligence, Fintech TwoStep Therapeutics, Genius AI, Century Health 4 153 103 6 In the CSV
16 Digitalis Ventures Venture capital firm New York, United States Health care, Biotech T-Therapeutics, Elemental Machines, Reema Health 3 105 17 8 •••@digitalisventures.com 646.49••• In the CSV
17 VentureOut Startup accelerator, Startup incubator New York, United States Hardware, Artificial intelligence Craif, Computomics, VisioLab 4 1,090 408 133 •••@ventureoutny.com 212.72••• In the CSV
18 Deerfield Hedge fund New York, United States Health care, Biotech Reprieve Cardiovascular, Cohere Health, Insilico Medicine 319 147 143 •••@cure.345pas.com +1 212••• In the CSV
19 Pfizer Venture Investments Corporate venture arm New York, United States Biotech, Health care FoRx Therapeutics 1 195 51 52 In the CSV
20 RTW Investments Hedge fund New York, United States Biotech, Health care Windward Bio, CORXEL Pharmaceuticals 2 142 41 80 •••@rtwfunds.com +1 646••• In the CSV
21 Pfizer Corporate venture arm, Venture capital firm New York, United States Biotech, Health care Circle Pharma, CellCentric, FoRx Therapeutics 3 55 22 20 1-800-••• In the CSV
22 FJ Labs Micro VC fund, Venture capital firm New York, United States Fintech, Commerce Firmly.ai, Formic, RepRally 24 1,801 63 165 (415) ••• In the CSV
23 BlackRock Investment bank, Private equity firm New York, United States Artificial intelligence, Fintech Snorkel AI, Deepgram, Groq 16 472 180 180 •••@blackrock.com 212-81••• In the CSV
24 Goldman Sachs Investment bank, Venture capital firm New York, United States Fintech, Hardware Job&Talent, Addi, Digital Asset 7 1,187 450 480 •••@gs.com In the CSV
25 Forum Ventures Startup accelerator New York, United States Artificial intelligence, Fintech CARA, Samply, Allen Control Systems 8 633 152 59 •••@forumvc.com In the CSV
26 General Atlantic Private equity firm, Venture capital firm New York, United States Fintech, Commerce ThreatLocker, Fresha, Sierra Space 4 552 303 195 •••@generalatlantic.com +1 212••• In the CSV
27 Warburg Pincus Private equity firm New York, United States Fintech, Commerce Varo Bank 1 528 344 195 •••@warburgpincus.com 212 87••• In the CSV
28 Everywhere Ventures Venture capital firm New York, United States Artificial intelligence, Fintech VAMA, North.cloud, Biotia 15 481 8 31 •••@everywhere.vc In the CSV
29 (ERA) Entrepreneurs Roundtable Accelerator Startup accelerator New York, United States Artificial intelligence, Commerce Pathways Technologies, Daptic, NOX Energy 11 466 9 50 •••@eranyc.com 212-55••• In the CSV
30 Golden Seeds Angel group, Venture capital firm Flushing, United States Artificial intelligence, Health care EliseAI, Materna Medical 2 154 32 18 •••@goldenseeds.com (888) ••• In the CSV

Table 2. Biotech investors in New York, United States: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 72.

Most active in the last 12 months

By portfolio companies funded
#InvestorLocation Funded, 12 monthsPortfolioLatest
1 Techstars New York, United States 67 2,132 Zipline International, Intuitivo, MuukTest
2 Tiger Global Management New York, United States 27 289 Harbinger, Easol, Mach9
3 FJ Labs New York, United States 24 412 Firmly.ai, Formic, RepRally
4 BoxGroup New York, United States 22 219 Nominal, Northwood Space, Reflex
5 Pareto Holdings New York, United States 22 222 Mural, Jar, Ryft
6 Insight Partners New York, United States 17 347 Coast, Reco, Island
7 BlackRock New York, United States 16 56 Snorkel AI, Deepgram, Groq
8 Everywhere Ventures New York, United States 15 164 VAMA, North.cloud, Biotia
9 Lux Capital New York, United States 12 85 Nominal, Formic, Meow
10 (ERA) Entrepreneurs Roundtable Accelerator New York, United States 11 173 Pathways Technologies, Daptic, NOX Energy
11 JP Morgan New York, United States 9 23 Capitolis, Tabby, Socure
12 Forum Ventures New York, United States 8 201 CARA, Samply, Allen Control Systems
13 Coatue New York, United States 8 92 Island, Together AI, Verse
14 OrbiMed New York, United States 8 46 Triveni Bio, Windward Bio, Terremoto Biosciences
15 Collaborative Fund New York, United States 7 69 Hylight, Hippo Harvest, Verse

Table 3. Biotech investors in New York, United States: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Latest rounds in their portfolios

Newest first
10 rows
Company What they do Sector Location Last round Amount Date Total raised Investors on this list Employees Founded
Nominal Nominal develops software platforms that help hardware engineering teams test, monitor, and analyze operational data. Software Los Angeles, United States Series C $240.0M 2026-11-09 $422.5M Lux Capital, BoxGroup 251 to 500 2022
Zipline International Unicorn Zipline designs, manufactures, and operates drones that deliver medical products. Hardware South San Francisco, United States Series I $1.5B 2026-11-05 $3.6B Techstars 1,001 to 5,000 2011
T-Therapeutics T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. Biotech Cambridge, United Kingdom Series B $133.0M 2026-11-05 $224.6M Digitalis Ventures 51 to 100 2022
Firmly.ai Firmly.ai operates an agentic commerce platform for product discovery and checkout across AI and digital channels. Fintech Seattle, United States Series A $15.0M 2026-11-05 $17.0M FJ Labs 51 to 100 2019
Northwood Space Northwood Space designs ground infrastructure and deployable systems for spacecraft communication and data handling. Hardware Los Angeles, United States Series C $375.0M 2026-11-02 $536.3M BoxGroup 101 to 250 2023
Reflex Reflex is an open-source Python framework for building and deploying web applications. Software San Francisco, United States Series A $14.0M 2026-10-29 $19.5M BoxGroup 11 to 50 2023
Easol Easol provides software for managing bookings, ticketing, payments, and customer relationships. Commerce London, United Kingdom Series A $20.0M 2026-10-28 $59.6M Tiger Global Management 11 to 50 2017
VAMA VAMA is a virtual platform giving devotees online access to e-pujas, e-darshans, and astrology services. Software New Delhi, India Seed $2.0M 2026-10-28 $7.4M Everywhere Ventures 101 to 250 2020
Intuitivo Intuitivo offers a digital assessment platform that improves teacher productivity and student experience. Education Porto, Portugal Seed $1.5M 2026-10-23 $1.6M Techstars 11 to 50 2021
Formic Formic makes automation deployments simple and accessible for organizations. Artificial intelligence Bolingbrook, United States Series B $40.0M 2026-10-22 $109.4M FJ Labs, Lux Capital 101 to 250 2020

Table 4. Biotech investors in New York, United States: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.

Portfolio sectors

Portfolio sectorsCompaniesShare
Software 4,181 78%
Artificial intelligence 1,340 25%
Fintech 1,112 21%
Health care 786 15%
Commerce 744 14%
Hardware 704 13%
Biotech 295 5%
Education 295 5%
Cybersecurity 267 5%
Energy 90 2%

Table 5. Biotech investors in New York, United States: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Investment stages

Table 6. Biotech investors in New York, United States by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesInvestorsShare
New York 70 97%
Flushing 1 1%
Ithaca 1 1%

Table 7. Biotech investors in New York, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Founded

FoundedInvestorsShare
2020s 9 13%
2010s 25 35%
2000s 14 20%
1990s 10 14%
1980s 7 10%
1970s 1 1%

Table 8. Biotech investors in New York, United States by founding decade. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech investors in New York, United States are on the list?
72, in the file dated 16 November 2026. 50 of them invested in a company whose most recent round falls in the last 12 months.
How many have an email address?
52 of the 72 carry an email address in the download and 47 a phone number.
What does the CSV contain?
One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
How much does the list cost?
$29 one-time for all 72 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV with 72 rows, 52 firm email addresses and 47 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 41 of the 52 are inboxes such as info@ or contact@. No partner names.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech investors in New York, United States: 72 rows, CSV, $29 one-time.

At once: the CSV with 72 rows, 52 firm email addresses and 47 phone numbers, on the page after payment and by mail.

The emails are the address a firm publishes: 41 of the 52 are inboxes such as info@ or contact@. No partner names.

Columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.

With partner contacts: $199 one-time. List CSV right after payment; up to 2 verified partner emails per firm compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech investors by city in New York

Investor types in New York

Other portfolio sectors in New York

Biotech investors elsewhere

Biotech startups

Cite: FundingWatcher, 72 biotech investors in New York, United States, 16 November 2026. https://fundingwatcher.com/investors/sector/biotech/new-york-united-states/